Trending

Coronavirus: 10 vaccines could be ready next year

Coronavirus: 10 vaccines could be ready next year FILE PHOTO: There are potentially 10 different coronavirus vaccines that could be available by the middle of next year if regulatory approval and patent protections go through. (Pool/Getty Images)

There are potentially 10 different coronavirus vaccines that could be available by the middle of next year if regulatory approval and patent protections go through.

>> Read more trending news

An international consortium of pharmaceutical companies said vaccines by Pfizer, BioNtech, Moderna and AstraZeneca have shown promise in clinical trials and other firms are expected to show similar results, Reuters reported.

“So far 3 we have 3 out of 3 were hits. I would expect that we will see something similar with Johnson & Johnson, I would expect that we would see similar positive results with Novavax, and many others, Sanofi Pasteur, GSK are in there, Merck,” Thomas Cueni, director of the International Federation of Pharmaceutical Manufacturers and Associations. “We will hopefully by the next summer have probably 10 vaccines which have proven their value. But all of them really need to be submitted by rigorous scientific scrutiny by the regulators.”

>> Coronavirus vaccine: How does the Pfizer vaccine work and when will it be available to everyone?

Pfizer said its vaccine has been shown to be 95% effective in a clinical trial. Moderna said an early analysis found its vaccine was 94.5% effective.

Coronavirus: Pfizer says vaccine 95% effective in final analysis of clinical trial

A vaccine offered by AstraZeneca has been clouded in controversy this week after some mistakes were found in the dosing of test subjects and might have to undergo more trials before it goes for regulatory approval.

>> AstraZeneca, University of Oxford COVID-19 vaccine under scrutiny after dosing mistake

The first patients in the U.S. could receive immunizations for the coronavirus Dec. 12, health officials said.

>> Coronavirus: US immunizations could start Dec. 12

The Food and Drug Administration advisory committee meets Dec. 10 and if Pfizer’s request for emergency use authorization is approved, its vaccine could begin shipment within 24 hours.

More coronavirus pandemic coverage:

>> Coronavirus: CDC acknowledges airborne transmission of COVID-19

>> Is it COVID-19, flu, cold or allergies? What is causing you to feel sick this year

>> Coronavirus: CDC updates guidance for COVID-19 testing

>> Dangerous hand sanitizer list up to more than 150 products, FDA announces

>> Wash your masks: How to clean a cloth face covering

>> Fact check: Will masks lower the oxygen level, raise the carbon dioxide in your blood?

>> How to not let coronavirus pandemic fatigue set in, battle back if it does

0